Results 211 to 220 of about 6,017,024 (357)

Carcinogenicity bioassays of vinyl chloride monomer: a model of risk assessment on an experimental basis.

, 1981
C Maltoni, Giuseppe Lefemine, Adriano Ciliberti, G. Cotti, D Carretti   +4 more
openalex   +1 more source

Pharmacokinetics and expert systems as aids for risk assessment in reproductive toxicology. [PDF]

, 1987
Donald R. Mattison, Frederick R. Jelovsek   +1 more
openalex   +1 more source

Mechanical Thrombectomy for TRACE‐III‐Eligible Patients With Ischemic Stroke: A Multicenter Retrospective Study Compared to TRACE‐III and TIMELESS Trials

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The results of the TRACE‐III trial demonstrated that tenecteplase (TNK) might be comparable to TNK combined with mechanical thrombectomy (MT) for large vessel occlusion (LVO) stroke within 4.5 to 24 h of onset, as tested in the TIMELESS trial.
Chongyang Huang, Yanru Liu, Jiangang Zhang, Sheng Guan, Tao Quan, Zhen Chen, Xiaojie Fu, Sen Wei, Kaihao Han, Xiaoan Zhou, Chengcheng Zhu, Edgar Samaniego, Yueqi Zhu, Haowen Xu   +13 more
wiley   +1 more source

Cardiometabolic risk assessment by anthropometric and biochemical indices in mexican population. [PDF]

Front Endocrinol (Lausanne)
Quirino-Vela L, Mayoral-Chavez M, Pérez-Cervera Y, Ildefonso-García O, Cruz-Altamirano E, Ruiz-García M, Alpuche J.   +6 more
europepmc   +1 more source

Performance of Composite Endpoints Defining Progression Independent of Relapse Activity in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The characteristics and utility of composite progression independent of relapse activity (cPIRA; worsening on the Expanded Disability Status Scale [EDSS], or 9‐Hole Peg Test, or Timed 25‐Foot Walk Test) were evaluated as an endpoint in relapsing multiple sclerosis (RMS) trials using the ENSEMBLE (NCT03085810) and pooled OPERA I/II ...
Ludwig Kappos, Sean Yiu, Jason Reucassel, Jiwon Oh, Cristina Granziera, Joep Killestein, Robert A. Bermel, Claude Berge, Agne Kazlauskaite, Hans‐Martin Schneble, Frank Dahlke, Bruce A. C. Cree   +11 more
wiley   +1 more source

A scoping review of artificial intelligence applications in clinical trial risk assessment. [PDF]

NPJ Digit Med
Teodoro D, Naderi N, Yazdani A, Zhang B, Bornet A.   +4 more
europepmc   +1 more source

Consistencies and inconsistencies underlying the quantitative assessment of leukemia risk from benzene exposure.

, 1989
Steven H. Lamm, Anthony Walters, Richard Wilson, Daniel M. Byrd, Hans Grünwald   +4 more
openalex   +1 more source

Continuous Monitoring of Bladder Dysfunction in People With Multiple Sclerosis: Wearables for the Bladder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Bladder dysfunction affects over 85% of people with multiple sclerosis (PwMS), yet current assessment methods are limited to periodic in‐clinic evaluations or subjective patient reports, failing to capture real‐world symptom fluctuations.
Valerie J. Block, Shane Poole, Leah McIntyre, Nikki Sisodia, Chelyn Park, Gabby Joseph, Michelle E. Van Kuiken, Anne M. Suskind, Riley Bove   +8 more
wiley   +1 more source

Co-occurrence and risk assessment of ochratoxin A and deoxynivalenol in tortillas. [PDF]

Mycotoxin Res
Afacan FO, Odabas E, Yussuf NH, Kabak B.
europepmc   +1 more source

(Biologically based methods for cancer risk assessment)

, 1988
C. C. Travis
openalex   +2 more sources